Primas Ronald A MD is categorized under Temporary Medical Services in New York City, NY and active since 1997.
Primas Ronald A MD was established in 1997, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Temporary Medical Services business, which does work in the B2B market, and is classified as a Temporary Medical Services, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Ronald Primas at the company’s single location by writing to 952 5th Avenue Apartment 1d, New York City, New York NY 10075 or by phoning (212) 737-1212. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Primas Ronald A MD |
Contact Person: | Ronald Primas |
Address: | 952 5th Avenue Apartment 1d, New York City, New York 10075 |
Phone Number: | (212) 737-1212 |
Website Address: | travelmd.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1997 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Temporary Medical Services |
SIC Code: | 7363 |
NAICS Code: | 6211110 |
Share This Business: |
Primas Ronald A MD was started in 1997 to provide professional Temporary Medical Services under the SIC code 7363 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Ronald Primas for inquiries that concern Primas Ronald A MD by calling the company number (212) 737-1212, as your correspondence is most welcome. Additionally, the physical location of the single location of Primas Ronald A MD can be found at the coordinates 40.774875,-73.962765 as well as the street address 952 5th Avenue Apartment 1d in New York City, New York 10075.
For its online presence, you may visit Primas Ronald A MD’s website at travelmd.com and engage with its social media outlets through on Twitter and on Facebook.